CSNK1D and head and neck squamous cell carcinoma: Furthermore, we observed higher mRNA levels of CSNK1D in HNSCC patients with a higher pathological grade and at advanced clinical stage than those with the low grade and at an early stage, which was also observed in HNSCC patients with lymph node metastasis (Fig. 1e).